share_log

Ansys Analyst Ratings

Benzinga ·  Nov 14, 2023 07:41
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/14/2023 3.27% B of A Securities $356 → $295 Downgrades Buy → Underperform
11/03/2023 16.23% Rosenblatt $320 → $332 Maintains Buy
11/03/2023 12.03% Oppenheimer $400 → $320 Maintains Outperform
11/03/2023 1.52% RBC Capital $310 → $290 Maintains Sector Perform
08/04/2023 8.52% RBC Capital → $310 Reiterates Sector Perform → Sector Perform
08/04/2023 12.03% Rosenblatt → $320 Reiterates Buy → Buy
07/14/2023 6.07% Barclays $292 → $303 Maintains Underweight
05/05/2023 19.38% Citigroup $347 → $341 Maintains Neutral
05/05/2023 8.52% RBC Capital $292 → $310 Maintains Sector Perform
04/24/2023 21.48% Citigroup $326 → $347 Maintains Neutral
04/18/2023 10.27% Loop Capital $310 → $315 Maintains Hold
04/17/2023 -1.98% Mizuho $260 → $280 Maintains Neutral
04/13/2023 2.22% Barclays $266 → $292 Maintains Underweight
02/27/2023 5.02% JP Morgan $275 → $300 Maintains Overweight
02/27/2023 8.52% Rosenblatt $270 → $310 Maintains Buy
02/24/2023 2.22% RBC Capital $248 → $292 Maintains Sector Perform
02/24/2023 -8.98% Mizuho $220 → $260 Maintains Neutral
02/24/2023 14.48% Baird $305 → $327 Maintains Outperform
02/24/2023 8.52% Rosenblatt $270 → $310 Maintains Buy
02/06/2023 6.77% Baird $295 → $305 Maintains Outperform
01/11/2023 -20.88% Barclays $200 → $226 Maintains Underweight
12/14/2022 3.27% Baird $281 → $295 Upgrades Neutral → Outperform
12/08/2022 -22.98% Mizuho $210 → $220 Maintains Neutral
11/04/2022 -26.48% Mizuho $225 → $210 Maintains Neutral
11/04/2022 -13.18% RBC Capital $260 → $248 Maintains Sector Perform
11/04/2022 -4.08% Credit Suisse $319 → $274 Maintains Outperform
10/24/2022 -5.48% Rosenblatt $295 → $270 Upgrades Neutral → Buy
10/17/2022 -21.23% Mizuho $285 → $225 Maintains Neutral
09/19/2022 -3.73% JP Morgan → $275 Reinstates → Overweight
08/17/2022 12.03% Wolfe Research → $320 Initiates Coverage On → Outperform
08/05/2022 -12.48% Barclays $245 → $250 Maintains Underweight
07/27/2022 -0.23% Oppenheimer → $285 Initiates Coverage On → Outperform
07/21/2022 -0.23% Rosenblatt $315 → $285 Maintains Neutral
07/19/2022 -7.23% Mizuho $285 → $265 Maintains Neutral
06/13/2022 12.03% Credit Suisse $339 → $320 Maintains Outperform
05/06/2022 18.68% Credit Suisse $389 → $339 Maintains Outperform
05/06/2022 10.27% Rosenblatt $324 → $315 Maintains Neutral
05/06/2022 -0.23% Mizuho $310 → $285 Maintains Neutral
03/29/2022 8.52% Mizuho → $310 Initiates Coverage On → Neutral
03/25/2022 -11.43% Daiwa Capital → $253 Initiates Coverage On → Sell
02/25/2022 36.18% Credit Suisse $437 → $389 Maintains Outperform
02/25/2022 22.53% RBC Capital $425 → $350 Maintains Sector Perform
02/25/2022 26.03% Rosenblatt $400 → $360 Maintains Neutral
01/06/2022 41.78% Baird $419 → $405 Downgrades Outperform → Neutral
11/08/2021 52.98% Credit Suisse $381 → $437 Maintains Outperform
11/05/2021 6.77% Barclays $275 → $305 Maintains Underweight
11/05/2021 48.78% RBC Capital $380 → $425 Maintains Sector Perform
08/06/2021 39.33% Credit Suisse $389 → $398 Maintains Outperform
08/06/2021 33.03% RBC Capital $360 → $380 Maintains Sector Perform
08/06/2021 29.53% Rosenblatt $340 → $370 Maintains Neutral
06/08/2021 19.03% Rosenblatt → $340 Initiates Coverage On → Neutral
04/12/2021 -64.99% B of A Securities → $100 Initiates Coverage On → Buy
02/26/2021 33.03% RBC Capital $400 → $380 Maintains Sector Perform
02/26/2021 37.23% Credit Suisse $413 → $392 Maintains Outperform
07/20/2020 -21.58% Barclays $210 → $224 Maintains Underweight
05/08/2020 7.82% Wedbush $280 → $308 Maintains Outperform
05/08/2020 -8.98% RBC Capital $230 → $260 Maintains Sector Perform
04/24/2020 -1.98% Wedbush $249 → $280 Maintains Outperform
03/13/2020 -12.83% Wedbush $295 → $249 Maintains Outperform
02/28/2020 6.77% Baird $323 → $305 Maintains Outperform
01/02/2020 Needham Downgrades Buy → Hold
12/12/2019 JP Morgan Downgrades Neutral → Underweight
11/19/2019 -7.23% Benchmark $235 → $265 Reiterates → Buy
11/08/2019 -17.73% Benchmark $230 → $235 Reiterates → Buy
09/16/2019 -22.98% Needham $210 → $220 Maintains Buy
09/13/2019 -11.08% Wedbush $232 → $254 Maintains Outperform
09/11/2019 -19.48% Benchmark $210 → $230 Maintains Buy
09/11/2019 -20.18% JP Morgan $190 → $228 Upgrades Underweight → Neutral
08/06/2019 -33.49% JP Morgan $160 → $190 Maintains Underweight
07/22/2019 Citigroup Initiates Coverage On → Buy
07/11/2019 -20.18% Wedbush $221 → $228 Maintains Outperform
04/10/2019 Keybanc Reinstates → Sector Weight
03/01/2019 -29.63% Wedbush $192 → $201 Maintains Outperform
12/19/2018 -43.29% Stifel → $162 Initiates Coverage On → Hold

What is the target price for Ansys (ANSS)?

The latest price target for Ansys (NASDAQ: ANSS) was reported by B of A Securities on November 14, 2023. The analyst firm set a price target for $295.00 expecting ANSS to rise to within 12 months (a possible 3.27% upside). 23 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Ansys (ANSS)?

The latest analyst rating for Ansys (NASDAQ: ANSS) was provided by B of A Securities, and Ansys downgraded their underperform rating.

When is the next analyst rating going to be posted or updated for Ansys (ANSS)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ansys, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ansys was filed on November 14, 2023 so you should expect the next rating to be made available sometime around November 14, 2024.

Is the Analyst Rating Ansys (ANSS) correct?

While ratings are subjective and will change, the latest Ansys (ANSS) rating was a downgraded with a price target of $356.00 to $295.00. The current price Ansys (ANSS) is trading at is $285.65, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment